Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis
International Journal of Rheumatic Diseases Feb 01, 2019
Shah S, et al. - Researchers assessed the data to estimate the importance of recognizing early onset cytopenia following rituximab (a monoclonal antibody against CD20 receptor ) in lupus nephritis. They noticed cytopenia including neutropenia as a late event (>4 weeks) in some cases. But a few cases of early-onset neutropenia (EON) and thrombocytopenia were also observed in the literature. They noted a good response of neutropenia to granulocyte colony-stimulating factor treatment and thus recovered the platelets spontaneously.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries